Ireland's trade surplus narrow, hit by lower pharma exports

17 February 2014

The overall trade surplus in the Republic of Ireland narrowed by 12.4% to 37.25 billion euros ($50.98 billion) in 2013, according to the Central Statistics Office, heavily impacted by the pharmaceutical sector.

It is the lowest annual trade surplus since 2008, said the CSO. This was caused by a 5.2% fall in the value of Irish exports, down 4.8 billion to 86.9 billion euros, coupled with a 1% increase in imports, to over 49.6 billion euros.

The CSO attributed the trade surplus narrowing to a sharp drop in the value of pharmaceutical and medical exports. The value of medical and pharmaceutical exports fell by over 2.9 billion euros to 21.62 billion euros, by far the biggest change on the 2012 figures.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical